Literature DB >> 1458677

Interference of Wegener's granulomatosis autoantibodies with neutrophil Proteinase 3 activity.

B A van de Wiel1, K M Dolman, C H van der Meer-Gerritsen, C E Hack, A E von dem Borne, R Goldschmeding.   

Abstract

Classic anti-neutrophil cytoplasmic autoantibodies (C-ANCA) are disease-specific markers of Wegener's granulomatosis (WG). The possible pathogenetic role of these autoantibodies, which are directed against Proteinase 3 (PR3), is not yet clear. We studied the effect of C-ANCA on PR3 proteolytic activity and on the complexation of PR3 with alpha 1-antitrypsin (alpha 1AT). C-ANCA IgG from eight patients with active WG significantly inhibited PR3 proteolytic activity, particularly towards elastin (median 84.2% inhibition). C-ANCA IgG significantly inhibited the complexation of PR3 with alpha 1AT (median 58.8% inhibition). Moreover, addition of purified PR3 to C-ANCA-positive sera from WG patients yielded less complexes with alpha 1AT (median 44.8%) compared with sera containing perinuclear anti-neutrophil cytoplasmic autoantibodies (P-ANCA) or ANCA-negative sera. These findings indicate the existence of a hitherto unknown property of C-ANCA, which may be of importance in the pathogenesis of WG.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1458677      PMCID: PMC1554581          DOI: 10.1111/j.1365-2249.1992.tb05860.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  26 in total

1.  Characterization of proteinase-3 (PR-3), a neutrophil serine proteinase. Structural and functional properties.

Authors:  N V Rao; N G Wehner; B C Marshall; W R Gray; B H Gray; J R Hoidal
Journal:  J Biol Chem       Date:  1991-05-25       Impact factor: 5.157

2.  Specificity of anti-neutrophil cytoplasmic autoantibodies for proteinase 3.

Authors:  J C Jennette; J R Hoidal; R J Falk
Journal:  Blood       Date:  1990-06-01       Impact factor: 22.113

Review 3.  Autoantibodies against myeloid lysosomal enzymes in crescentic glomerulonephritis.

Authors:  J W Tervaert; R Goldschmeding; J D Elema; M van der Giessen; M G Huitema; G K van der Hem; T H The; A E von dem Borne; C G Kallenberg
Journal:  Kidney Int       Date:  1990-02       Impact factor: 10.612

4.  Endocytosis and degradation of alpha 1-antitrypsin-protease complexes is mediated by the serpin-enzyme complex (SEC) receptor.

Authors:  D H Perlmutter; G Joslin; P Nelson; C Schasteen; S P Adams; R J Fallon
Journal:  J Biol Chem       Date:  1990-10-05       Impact factor: 5.157

5.  IgG subclass distribution of autoantibodies to neutrophil cytoplasmic antigens in systemic vasculitis.

Authors:  D R Jayne; A P Weetman; C M Lockwood
Journal:  Clin Exp Immunol       Date:  1991-06       Impact factor: 4.330

6.  Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro.

Authors:  R J Falk; R S Terrell; L A Charles; J C Jennette
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

7.  Production of monoclonal antibodies against inactivated alpha 1-antitrypsin. Cross-reactivity with complexed alpha 1-antitrypsin and application in an assay to determine inactivated and complexed alpha 1-antitrypsin in biological fluids.

Authors:  J J Abbink; A M Kamp; A J Swaak; C E Hack
Journal:  J Immunol Methods       Date:  1991-10-25       Impact factor: 2.303

8.  Prevention of relapses in Wegener's granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre.

Authors:  J W Tervaert; M G Huitema; R J Hené; W J Sluiter; T H The; G K van der Hem; C G Kallenberg
Journal:  Lancet       Date:  1990-09-22       Impact factor: 79.321

9.  Plasma elastase alpha 1-antitrypsin and lactoferrin in sepsis: evidence for neutrophils as mediators in fatal sepsis.

Authors:  J H Nuijens; J J Abbink; Y T Wachtfogel; R W Colman; A J Eerenberg; D Dors; A J Kamp; R J Strack van Schijndel; L G Thijs; C E Hack
Journal:  J Lab Clin Med       Date:  1992-02

10.  Anti-neutrophil cytoplasm antibodies in Wegener's granulomatosis recognize an elastinolytic enzyme.

Authors:  J Lüdemann; B Utecht; W L Gross
Journal:  J Exp Med       Date:  1990-01-01       Impact factor: 14.307

View more
  25 in total

Review 1.  Immunopathological aspects of systemic vasculitis.

Authors:  I M Bajema; E C Hagen; F Ferrario; E de Heer; J A Bruijn
Journal:  Springer Semin Immunopathol       Date:  2001

Review 2.  Are anti-neutrophil cytoplasmic antibodies (ANCA) clinically useful in inflammatory bowel disease (IBD)?

Authors:  C Roozendaal; C G Kallenberg
Journal:  Clin Exp Immunol       Date:  1999-05       Impact factor: 4.330

3.  Characterization of monoclonal antibodies to proteinase 3 (PR3) as candidate tools for epitope mapping of human anti-PR3 autoantibodies.

Authors:  Y M Van Der Geld; P C Limburg; C G Kallenberg
Journal:  Clin Exp Immunol       Date:  1999-12       Impact factor: 4.330

Review 4.  Antineutrophil cytoplasm antibodies and vasculitis.

Authors:  M C Nash; M J Dillon
Journal:  Arch Dis Child       Date:  1997-09       Impact factor: 3.791

5.  Catalase and alpha-enolase: two novel granulocyte autoantigens in inflammatory bowel disease (IBD).

Authors:  C Roozendaal; M H Zhao; G Horst; C M Lockwood; J H Kleibeuker; P C Limburg; G F Nelis; C G Kallenberg
Journal:  Clin Exp Immunol       Date:  1998-04       Impact factor: 4.330

6.  Binding of proteinase 3 and myeloperoxidase to endothelial cells: ANCA-mediated endothelial damage through ADCC?

Authors:  B E Ballieux; K T Zondervan; P Kievit; E C Hagen; L A van Es; F J van der Woude; M R Daha
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

7.  Detection and expression of a cDNA clone that encodes a polypeptide containing two inhibitory domains of human calpastatin and its recognition by rheumatoid arthritis sera.

Authors:  N Després; G Talbot; B Plouffe; G Boire; H A Ménard
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

Review 8.  B cell epitope specificity in ANCA-associated vasculitis: does it matter?

Authors:  Y M van der Geld; C A Stegeman; C G M Kallenberg
Journal:  Clin Exp Immunol       Date:  2004-09       Impact factor: 4.330

9.  Epitope mapping of anti-proteinase 3 and anti-myeloperoxidase antibodies.

Authors:  L Chang; S Binos; J Savige
Journal:  Clin Exp Immunol       Date:  1995-10       Impact factor: 4.330

Review 10.  Mechanisms of endothelial cell injury in vasculitis.

Authors:  A A Pall; C O Savage
Journal:  Springer Semin Immunopathol       Date:  1994
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.